[Management of patients with GERD. Clinical practice guideline. 2008 update. Clinical Practice Guideline Working Group on GERD].
Marzo
Mercè
M
Sociedad Española de Medicina de Familia y Comunitaria (semFYC). mmarzoc@gencat.cat
Carrillo
Ricard
R
Mascort
Juan José
JJ
Alonso
Pablo
P
Mearin
Fermín
F
Ponce
Julio
J
Ferrándiz
Juan
J
Fernández
Miren
M
Martínez
Gerardo
G
Sáez
Manuel
M
Bonfill
Xavier
X
Piqué
Josep Maria
JM
D000230:Adenocarcinoma / Q000209:etiology / Q000517:prevention & control; D000465:Algorithms; D000863:Antacids / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000209:etiology / Q000517:prevention & control; D003131:Combined Modality Therapy; D015897:Comorbidity; D003952:Diagnostic Imaging; D019468:Disease Management; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control; D004945:Esophagoscopy; D005260:Female; D018662:Fundoplication; D005764:Gastroesophageal Reflux / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery / Q000628:therapy*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D015995:Prevalence; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012307:Risk Factors
D000863:Antacids; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors